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December 20101744 AbstractsIntraluminal Stent Effects on Duplex Velocity Estimates
Christopher S. Kuppler, William B. Newton, III, Timothy E. Craven,
Racheed J. Ghanami, ShawnH. Fleming, Kimberley J. Hansen, Christopher
J. Godshall, Wake Forest University Baptist Medical Center, Winston-
Salem, NC
Background: To measure changes in duplex velocity estimates associ-
ated with balloon expandable (BES) and self-expandable (SES) endoluminal
stents.
Methods: An in vitro vascular circuit model consisting of a pulsatile
pump, tubing, and a conduit was created. The pump was programmed to
replicate the doppler spectral waveform pattern of the renal and carotid
arteries. Conduits consisted of Sylgard® (Dow Corning, Midland, MI)
tubing of variable compliance with differing wall thicknesses. An intralumi-
nal fluid was created using a cornstarch and water mixture which had an
average viscosity of 3.46 cP over the range of fluid velocities observed in this
study. Pressure was measured continuously by electromechanical transducer
at a site proximal to the conduit. Flow velocities were estimated with duplex
ultrasound utilizing a matrix linear array probe at 6-15 MHZ (GE Logic
E-9, GE Healthcare). Peak systolic velocity (PSV) and end-diastolic velocity
(EDV) were estimated at 5 distinct conduit locations. Three replicate
velocity measurements were made at each location. Diameter measurements
of the conduit at peak systole and end diastole were made, and change in
cross-sectional area calculated. After initial velocity estimates, a BES or SES
was deployed within the conduit. Velocity estimates were then repeated.
Three separate conduits were used. Analysis of PSV and EDV measured
under the three arterial conditions (unstented, BES, and SES) was per-
formed using mixed linear models that included a random effect to account
for clustering. Fixed effects were included for condition, location (five
segments marked on each conduit and denoted “A” - “E”), and replicate (1,
2, or 3). All analyses were performed using SAS version 9.2 software.
Results: Compliance was estimated for each conduit under each condi-
tion (unstented, BES, and SES). Values ranged from 3.12  103 to 8.43 
103mm2/mmHg. Average PSVs differed by condition.Mean SE PSVwas
95.8 2.6 cm/s, 97.0 2.7 cm/s, and101.4 2.7 cm/s for unstented, BES
and SES, respectively (P  .0001). Average PSVs differed significantly across
location (P .0001) and replicate (P .039); however, no interaction between
condition and either location or replicate were found. EDV values did not differ
significantly across condition. Mean  SE EDV was 36.2 1.0 cm/s,
37.3 1.1 cm/s, and 37.2 1.1 cm/s for unstented, BES and SES, respec-
tively (P .13). Average EDVs differed significantly across location (P .001)
but not across replicates (P .82). The direct effect of stenting on velocities was
assessed by examining paired differences between the unstented and stented
conduits calculated at each replicate. Mean  SE percent change in PSV was
1.0 3.3% for BES minus unstented, and 6.4 3.1% for SES minus un-
stented (P .24). Mean SE change in EDV was 1.3 5.3% for BES minus
unstented, and 3.5 4.4% for SES minus unstented (P  .79). Overall esti-
mates of the effect of stent placement (pooled across BES and SES types) were
3.7% (95% CI: 6.4%, 13.8%) for PSV, and 0.8% (95% CI: 7.1%, 8.3%) for
EDV.
Conclusions: The presence of BES and SES were associated with a less
than 7% change in estimated PSV. These results suggest that Doppler
velocity estimates for renal and carotid arteries are not materially affected by
either ballon expandable or self expandable endoluminal stents.
Hormone Replacement Therapy Influences Matrix Metalloproteinase
Expression and Intimal Hyperplasia Development after Vascular In-
jury: A Follow-Up Study
Richard B. Cook, Deidra J. Mountain, Stacy S. Kirkpatrick, James E. Chalk,
David C. Cassada, Scott L. Stevens, Michael B. Freeman, Mitchell H.
Goldman, Oscar H. Grandas, University of Tennessee Graduate School of
Medicine, Knoxville, Tenn
Background: Postmenopausal women taking hormone replacement
therapy (HRT) have increased intimal hyperplasia (IH) following vascular
intervention. Matrix metalloproteinases (MMPs) play a major role in IH
development, and we have shown that hormone exposure results in unbal-
anced MMP regulation in vascular smooth muscle cells in vitro. Previously
we presented data from a small pilot study suggesting a role for HRT in the
development of IH via MMP modulation in vivo, using a postmenopausal
rodent model of vascular injury. Here we further investigated the role of
HRT as a modulator of MMPs and IH in a larger follow-up study.
Methods: Female rats were aged to 12 months and ovariectomized
(OVX). Four weeks later estrogen (E), progesterone (P), estrogen  pro-
gesterone (E/P), or placebo (Plac) were delivered via 90-day slow-release
pellets. Following 6 weeks of HRT, each rat underwent balloon angioplasty
of the left common carotid artery. At 14 days postinjury, tissue samples were
collected and stained with Trichrome elastin for intima:media (I:M) mea-
surement and stained for various MMP isoforms.
Results: Following vascular injury I:M was decreased in OVX rats
compared to non-OVX controls (Fig 1, n 5-6, PNS). In OVX animals,
HRT exposure did not significantly increase the I:M ratios. (Fig 1, n 5-6,
P  NS). Injury-induced expression of MMP-2 and 9 was significantlydecreased in OVX animals compared to non-OVX controls (Table 1; n 
5-6). MMP-2 and 9 levels were subsequently increased by each type of
hormone therapy compared to placebo, with a significant increase in
MMP-9 in response to estrogen with and without progesterone (Table; n
5-6). Conversely, TIMP-2 was significantly decreased by estrogen compared
to placebo (Table; n  5-6). There was no effect on intimal MT1-MMP in
any group.
Table 1.
% intima stained
NonOVX C OVX - Plac OVX - E OVX - P OVX - EP
MMP-2 37.8  10.0 15.4  3.7* 26.5  3.7 38.8  7.6 38.5  7.6
MMP-9 4.3  0.1 2.7  0.4* 4.7  0.6# 6.0  1.3 7.1  1.0#
TIMP-2 50.9  8.9 22.2  3.4* 8.7  1.4# 24.8  10.1 28.2  9.4
*P  0.05 vs. NonOVX C
#P  0.05 vs. OVX-Plac
Conclusions: Here we were not able to demonstrate a statistically
significant decrease in IH as a result of ovariectomy. Furthermore, HRT at
the doses given did not remarkably increase IH. Here we also demonstrate a
significant reduction in MMP-2, 9, and TIMP-2 in response to ovariec-
tomy. Subsequent hormone exposure results in the upregulation of MMP-2
and9 without a counter-regulatory increase in TIMP. We have previously
shown elevation in MT1-MMP to occur during the initial phases of IH
development; therefore, examination earlier than 14 days postinjury is
needed to determine the effect of HRT on this MMP regulatory isoform.
Future studies should investigate in vivo manipulation of this unbalanced
MMP regulation for prevention of IH in response to HRT exposure.
National Trends in Repair of Intact Abdominal Aortic Aneurysms in
the Medicare Population
Mounir J. Haurani, Mark F. Conrad, Virendra I. Patel, Emel A. Ergul,
Christopher J. Kwolek, Richard P. Cambria, Massachusetts General Hospi-
tal, Harvard Medical School, Boston, Mass
Background: Endovascular abdominal aortic aneurysm repair (EVAR)
of intact abdominal aortic aneurysm (AAA) continues to gain favor despite
the perceived higher procedural costs when compared to open repair
(OPEN). National trends in AAA repair are unknown. This study aims to
compare regional utilization of EVAR, and its effects on patient mortality
and procedural costs.
Methods: All patients in the Medicare database who underwent AAA
repair from 2004 to 2007 were identified and stratified into OPEN and
EVAR cohorts. Geographic regions were created according to standard US
census divisions. Primary outcomes included perioperative mortality, long-
term survival and hospital cost.
Results: There were 103,033 patients identified, 68,370 EVAR
(66.4% ) vs 34,6633 OPEN (33.6%). Although EVAR is favored nationally,
there are significant differences in regional utilization (Table). Between
2004 and 2007, the total number of AAA repairs was not different (25,246
vs 25,850, P  NS), but the percentage of EVARS performed was signifi-
cantly higher in 2007 (14,001 [55%] vs 19,471 [75%], P  .001). The
national 30-daymortality was significantly higher after OPEN (4.9% vs 1.6%,
P  .001), however, long-term survival was equal(73.6% OPEN vs 74.6%
EVAR P  .04) with no regional differences (Table). Hospital charges for
EVARwere significantly less than open ($64,380 EVAR vs $68,174 OPEN,
P  .0001), as was Medicare reimbursement ($19,367 EVAR vs $23,474
OPEN, P  .001). This is likely due to an increased length-of-stay in the
OPEN cohort (3.5 days EVAR vs 9.9 days OPEN, P  .001)
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national EVAR utilization increased over the study period. Perioperative
mortality was lower after EVAR but there was no difference in long-term
survival and no regional differences in mortality for either cohort. In
addition, EVAR was performed with a lower hospital cost than OPEN. This
large national study further supports the use of EVAR as the first-line therapy
for intact AAA.
Midwest Northeast South West National
Number of patients OPEN 10,195 6175 13,571 4722 34,663
EVAR 18,433 13,012 28,102 8,823 68,370
%EVAR 64.4% 67.8% 67.4% 65.1% 66.4%
P  .001
30-mortality OPEN 4.9% 4.8% 5.0% 4.6% 4.9%
EVAR 2.6% 1.9% 2.4% 2.5% 1.6%
P  .001 (OPEN vs EVAR)
5-year survival OPEN 74.4% 73.8% 72.7% 74.1% 73.6%
EVAR 75.5% 73.6% 74.1% 75.3% 74.6%
(P  .4 for OPEN vs EVAR, P  .9 for regions)
Randomized Clinical Trial of Open-Cell vs Closed-Cell Stents for
Carotid Stenting: Effects of Stent Design on Cerebral Embolization
Carlos H. Timaran, Eric B. Rosero, Adriana Higuera, Adriana Ilarraza, J.
Gregory Modrall, G. Patrick Clagett, University of Texas, SW Medical
Center, Dallas, Tex
Background: The effect of stent design on cerebral embolization has
not been established. The purpose of this trial was to contrast the incidence
of cerebral embolization in high-risk patients undergoing carotid artery
stenting (CAS) with open-cell vs closed-cell stents.
Methods: During an 18-month period, 40 patients were randomized
(1:1) to undergo CASwith open-cell (Acculink, n 20) or closed-cell stents
(Xact, n  20). A single filter device for embolic protection (Accunet filter)
was used. Transcranial Doppler (TCD)-detected microembolic signals
(MES) during CAS and pre- and 24-hour postprocedural diffusion-
weighted magnetic resonance imaging (DW-MRI) were used to determine
cerebral embolization. Univariate and nonparametric analyses were used to
assess associations between stent design and cerebral embolization.
Results: CAS was performed in 16 (41%) symptomatic and 24 (59%)
asymptomatic patients with equal number of open-cell and closed-cell stents
(8/8 and 12/12, respectively). The total and poststenting median MES
counts detected by TCD were 225 (interquartile range [IQR], 191-257)
and 59 (IQR, 43-123) for open-cell stents and 281 (IQR, 134-372) and 74
(IQR, 41-88) for closed-cell stents, respectively (P .4). New acute cerebral
emboli detected with DW-MRI occurred in 47% and 53% of patients
undergoing CAS with open-cell and closed-cell stents, respectively (P .9).
The total and ipsilateral median number of DW-MRI lesions between
groups were not statistically significantly different, ie, 1.5 (IQR, 0-3.75) and
1 (IQR, 0-2) for open-cell stents and 2 (IQR, 0-3) and 1 (IQR, 0-3) for
closed cell-stents, respectively (P  .7). One asymptomatic patient under-
going CAS with an open-cell stent sustained a minor stroke; the 30-day
stroke-death rate in this series was 2.5%.
Conclusions: Cerebral embolization, as detected by TCD and DW-
MRI, occurs with similar frequency after CAS with open-cell and closed-cell
stents. This randomized trial does not support the superiority of any stent
design with respect to cerebral embolization.
Timing of Venous Thromboembolism After Colorectal Cancer Resec-
tion
Eleftherios Xenos, Daniel L. Davenport, David J. Minion, Ehab E. Sorial,
Shane D. O’Keeffe, Eric D. Endean, University of Kentucky Medical Cen-
ter, Lexington, Ky
Background: Deep vein thrombosis (DVT) and pulmonary embolism
(PE) are significant sources of postoperative morbidity and mortality and are
currently major quality improvement initiatives. Mechanical and pharmaco-
logical prophylaxis is effective in preventing postoperative thromboembolic
events, thromboprophylaxis is usually discontinued after discharge. We
postulated that patients may still be at risk of venous thromboembolic
disease (VTE) after discharge and and tested this hypothesis in patients
undergoing colorectal resection for cancer, a high-risk population.
Methods: The ACS NSQIP database was queried for patients under-
going colorectal resections for cancer based on the primary procedure CPT
code and operative ICD-9 diagnosis code from 2005 to 2008. The outcome
analyzed was 30-day DVT and/or PE. DVT/PE occurrences were analyzed
by postoperative day, rate relative to hospital length of stay, and by whether
they occurred in-hospital or after initial discharge. Multivariable forward
stepwise regression (P for entry  .05, for exit  .10) was used to identify
independent predictors of DVT.Results: The database contained 21,943 colorectal cancer resections.
DVT/PE (both inpatient and outpatient) rates increased linearly from 0.8%
in patients with length of stay (LOS) less than 1 week to 11.6% in patients
with LOS greater than 3weeks (2 test for linear trend, P .001, Fig 1). The
DVT rate was 1.4% (306/21,943) of which 29% (89/306) were diagnosed
post discharge. The PE rate 0.8% (180/21,943) of which 33% (60/180)
were diagnosed post discharge. Patients were diagnosed with both only 40
times and the combined DVT or PE rate was 2.0% (446/21,943). The ratio
of outpatient to inpatient VTE rate as related to days that elapsed from the
surgical procedure is shown in Figure 2. Independent risk factors for
postdischarge DVT/PE were preoperative steroid use for chronic condition
(n  575, odds ratio 2.90, 95% CI 1.51-5.57, P  .001) and preoperative
systemic inflammatory response syndrome (n  875, odds ratio 2.26, 95%
CI 1.24-4.10, P  .008)
Conclusions:Analysis of theNSQIP database shows increasing rates of
VTE as hospital LOS increases. It was surprising to find that diagnosis of
almost 1/3 of postoperative VTE in this patient population occurs after
discharge. The duration of the prothrombotic stimulus of surgery is not well
defined and patients with malignancy are at high risk of VTE. It is conceiv-
able that thromboprophylaxis after discharge should be considered for these
patients. Additional studies may identify other patient groups in similar risk.
Diastolic Function Predicts Survival After Renal Revascularization
Racheed J. Ghanami1, Hamza Rana1, Tim Craven1, Matthew A Corriere2,
Phillip Moore1, John Hoyle1, Randolph L. Geary1, Matthew S Edwards1,
Christopher J Godshall1, Kimberley J. Hansen1, 1Wake Forest University
Baptist Medical Center, Winston-Salem, NC; 2Emory University School of
Medicine, Atlanta, Ga
Background: To define the relationship between left ventricular dia-
stolic function and survival after renal revascularization.
Methods: Seventy-six adult patients (49 women, 27 men; mean age:
63 years  13 years) with preoperative echocardiography who underwent
renal revascularization for atherosclerotic disease were identified. Echocar-
diograms were performed and interpreted according to American Society of
Echocardiography Recommendations for Use of Echocardiography in Clin-
ical Trials. Diastolic function was estimated by measuring the early diastolic
